SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+15.0%
5Y CAGR+13.4%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+15.0%/yr
vs +13.3%/yr prior
5Y CAGR
+13.4%/yr
Consistent
Acceleration
+1.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $278.15B | +13.9% |
| 2024 | $244.24B | +11.5% |
| 2023 | $219.04B | +19.8% |
| 2022 | $182.91B | +19.8% |
| 2021 | $152.73B | +3.0% |
| 2020 | $148.34B | +17.1% |
| 2019 | $126.66B | +14.2% |
| 2018 | $110.90B | -30.1% |
| 2017 | $158.64B | +8.6% |
| 2016 | $146.10B | - |